Overview Follow the Money Daily Brief Live Congress Directory Corporate Insiders Planned Sales & Stakes Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist

Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology

Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…

Overview Follow the Money Daily Brief Live Congress Directory Corporate Insiders Planned Sales & Stakes Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology

Overview Follow the Money Daily Brief Live Congress Directory Corporate Insiders Planned Sales & Stakes Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist

Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology

Overview Follow the Money Daily Brief Live Congress Directory Corporate Insiders Planned Sales & Stakes Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology

Acurx Pharmaceuticals, Inc. (ACXP) · INSIDER

Data sources

SEC Form 43h ago

House PTR3h ago

SEC 13F3h ago

Robinhood Chain3h ago

Public company

Acurx Pharmaceuticals, Inc.

ACXPCIK 0001736243

EDGAR filings Open in network

Price$1.06

1 year-79.4%

Disclosed transactions0

Buys / sells0 / 0

Max Insider Score—

Connections with evidence2

ACXP · disclosed activity on price

Disclosed transactions

No records

No transactions recorded for this profile.

Verified connections

In industryevidence
Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
← Lobbied forevidence
INNOVATIVE FEDERAL STRATEGIES, LLCLDA Q2 2026 second quarter · Budget/appropriations · Aug 26, 2026

Lobbying

$60K reported · de-duplicated

2026 Q2 $30K via firms2026 Q1 $30K via firms

INNOVATIVE FEDERAL STRATEGIES, LLC$30K2026 Q1 · posted Aug 26, 2026 · Budget/appropriations
INNOVATIVE FEDERAL STRATEGIES, LLC$30K2026 Q2 · posted Aug 26, 2026 · Budget/appropriations

Connected PAC contributions

FEC · direct to members

No contributions from a PAC connected to this company.